Lessons From the Current Japanese Triple Helix Model

Since mid-1990s, the Japanese government has encouraged university-industry collaboration to foster innovations for economic growth. Learning from the American licensing model of technology transfer, Japanese Bay-Dole Act and TLO (Technology Licensing Organization) Act were enacted in late 1990s. In addition, the corporatization of Japanese National Universities (JNUs) in 2004 spurred their technology-transfer activities to obtain external funds. As a result, more than 50 TLOs has been established since FY1998, and also the number of patent application and licensed patents were increased at JUNs rapidly after FY2004. However, the licensing income has been stayed poor and some of TLOs were abolished. There are few evidences that the introduction of licensing model of technology transfer into Japan could contribute to innovation properly. Therefore, this study will try to clarify if licensing model of technology transfer work in Japan by analyzing the Japanese National University (JNU) patent. There are 20,485 applied patent, which invented by JNU's researcher(s) from FY2004 to 2007. 38% of them were applied by solely by JNUs and 52% were by JNU and Private Firms etc. In the Japanese Patent Act, jointly applied patents are not licensed to the third party without the consent of co-applicant(s). Hence, more than half of the patent invented by JNU researchers is not basically used for patent licensing. Consequently, JNUs and TLOs face difficulties in patent licensing under the current Patent Act

Precise navigation surgery of tumours in the lung in mouse models enabled by in situ fluorescence labelling with a killer-reporter adenovirus.

BackgroundCurrent methods of image-guided surgery of tumours of the lung mostly rely on CT. A sensitive procedure of selective tumour fluorescence labelling would allow simple and high-resolution visualisation of the tumour for precise surgical navigation.MethodsHuman lung cancer cell lines H460 and A549 were genetically transformed to express red fluorescent protein (RFP). Tumours were grown subcutaneously for each cell line and harvested and minced for surgical orthotopic implantation on the left lung of nude mice. Tumour growth was measured by fluorescence imaging. After the tumours reached 5 mm in diameter, they were injected under fluorescence guidance with the telomerase-dependent green fluorescent protein (GFP)-containing adenovirus, OBP-401. Viral labelling of the lung tumours with GFP precisely colocalised with tumour RFP expression. Three days after administration of OBP-401, fluorescence-guided surgery (FGS) was performed.ResultsFGS of tumours in the lung was enabled by labelling with a telomerase-dependent adenovirus containing the GFP gene. Tumours in the lung were selectively and brightly labelled. FGS enabled complete lung tumour resection with no residual fluorescent tumour.ConclusionsFGS of tumours in the lung is feasible and more effective than bright-light surgery

Fluorescence-guided surgery of a highly-metastatic variant of human triple-negative breast cancer targeted with a cancer-specific GFP adenovirus prevents recurrence.

We have previously developed a genetically-engineered GFP-expressing telomerase-dependent adenovirus, OBP-401, which can selectively illuminate cancer cells. In the present report, we demonstrate that targeting a triple-negative high-invasive human breast cancer, orthotopically-growing in nude mice, with OBP-401 enables curative fluorescence-guided surgery (FGS). OBP-401 enabled complete resection and prevented local recurrence and greatly inhibited lymph-node metastasis due to the ability of the virus to selectively label and subsequently kill cancer cells. In contrast, residual breast cancer cells become more aggressive after bright (white)-light surgery (BLS). OBP-401-based FGS also improved the overall survival compared with conventional BLS. Thus, metastasis from a highly-aggressive triple-negative breast cancer can be prevented by FGS in a clinically-relevant mouse model

Processing and mechanical properties of hollow sphere aluminum foams

Hollow sphere metallic foams are a new class of cellular material that possesses the attractive advantages of uniform cell size distribution and regular cell shape. These result in more predictable physical and mechanical properties than those of cellular materials with a random cell size distribution and irregular cell shapes. In the present study, single aluminum hollow spheres with three kinds of sphere wall thickness as 0.1 mm, 0.3 mm and 0.5 mm were processed by a new pressing method. Hollow sphere aluminum foam samples were prepared by bonding together single hollow spheres with simple cubic packing (SC) and body-centered cubic packing (BCC). Compressive tests were carried out to evaluate the deformation behaviors and mechanical properties of the hollow sphere aluminum foams. Effects of the sphere wall thickness and packing style on the mechanical properties were investigated.<br /

Improved Resection and Outcome of Colon-Cancer Liver Metastasis with Fluorescence-Guided Surgery Using In Situ GFP Labeling with a Telomerase-Dependent Adenovirus in an Orthotopic Mouse Model.

Fluorescence-guided surgery (FGS) of cancer is an area of intense development. In the present report, we demonstrate that the telomerase-dependent green fluorescent protein (GFP)-containing adenovirus OBP-401 could label colon-cancer liver metastasis in situ in an orthotopic mouse model enabling successful FGS. OBP-401-GFP-labeled liver metastasis resulted in complete resection with FGS, in contrast, conventional bright-light surgery (BLS) did not result in complete resection of the metastasis. OBP-401-FGS reduced the recurrence rate and prolonged over-all survival compared with BLS. In conclusion, adenovirus OBP-401 is a powerful tool to label liver metastasis in situ with GFP which enables its complete resection, not possible with conventional BLS

Acquisition of Maltose Chemotaxis in Salmonella typhimurium by the Introduction of the Escherichia coli Chemosensory Transducer Gene

Escherichia coli and Salmonella typhimurium are closely related species. However, E. coli cells show maltose chemotaxis but S. typhimurium cells do not. When an E. coli chemotransducer gene (tar_E), the product of which is required for both aspartate and maltose chemotaxis, was introduced by using a plasmid vector into S. typhimurium cells with a defect in the corresponding gene (tar_S), the transformant cells acquired the ability for both aspartate and maltose chemotaxis. In contrast, when the tar_s gene was introduced into tar_E-deficient E. coli cells, the transformant cells acquired aspartate chemotaxis but not maltose chemotaxis. These results indicate that the absense of maltose chemotaxis in S. typhimurium is a consequence of the properties of the tar_s gene product